ClinicalTrials.Veeva

Menu

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions. (LACOG 1818)

L

Latin American Cooperative Oncology Group (LACOG)

Status

Active, not recruiting

Conditions

Prostatic Neoplasms, Castration-Resistant

Study type

Observational

Funder types

Other

Identifiers

NCT04962919
LACOG 1818

Details and patient eligibility

About

Survival outcomes in metastatic prostate cancer in the population Brazilian - analysis of individual characteristics and modalities of treatment in different national health institutions

Enrollment

584 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of castration-resistant metastatic prostate cancer diagnosed in the period between January 2014 and December 2017.

Exclusion criteria

  • Diagnosis of localized or locally advanced or metastatic disease sensitive to castration;
  • Patients with medical records filled with incomplete data that make it impossible to evaluate the treatment received.

Trial design

584 participants in 2 patient groups

Public institution
Description:
Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017
Private institution
Description:
Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017

Trial contacts and locations

8

Loading...

Central trial contact

Gustavo Werutsky, MD; Fernando Maluf, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems